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Introduction: The primary aim of this study was to evaluate the ability of radiologists to accu-
rately estimate pneumothorax and pulmonary haemorrhage during percutaneous co-axial
cutting needle CT-guided lung biopsy.
Methodology: Patients undergoing cutting needle lung biopsy during the study period were
identified; the path taken by the cutting needle marked on each pre-biopsy staging CT scan.
Each scan was then reviewed independently by two thoracic radiologists blinded to clinical
details and complications; pneumothorax and pulmonary haemorrhage risk estimated with
a percentage Visual Analogue Scale.
Results: In 134 patients, pneumothorax occurred in 24%. The radiologists differed in the esti-
mation of pneumothorax risk in 55% (74 episodes). When pneumothorax risk was estimated
<20% by radiologists 1 and 2, 16% and 14% of biopsies resulted in pneumothorax; where risk
was estimated at 20e49%, pneumothorax incidence rose to 33% and 31%; where risk was
deemed 50%, pneumothorax rate was 87% and 100%. Pulmonary haemorrhage occurred in
4%; estimated haemorrhage risk for biopsies complicated by haemorrhage did not differ signif-
icantly from where haemorrhage did not occur.ospital Aintree, Lower Lane, Liverpool L9 7AL, UK. Tel.: þ44 151 529 2962; fax: þ44 151 529 5888.
k (B. Chakrabarti).
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450 B. Chakrabarti et al.Conclusion: Radiologists differ markedly in the estimation of pneumothorax risk for a patient
undergoing co-axial lung biopsy. Identifying individual patients developing pneumothorax was
only possible when risk was estimated at 50%. Pulmonary haemorrhage was uncommon and
difficult to predict accurately.
ª 2008 Elsevier Ltd. All rights reserved.Introduction
Percutaneous CT-guided trans-thoracic biopsy (PCTTB) is
widely performed during the investigation of parenchymal
lung lesions. Percutaneous lung biopsy using a co-axial
cutting needle has been described to reduce the number of
passes through the pleura and improves the yield of the
biopsy with a reported diagnostic sensitivity exceeding
90%.1,2 However, the procedure does carry risk of morbidity
and occasional mortality.1,3e6 Commonly recognised
complications include pneumothorax, reported in approxi-
mately 20% of cases, and pulmonary haemorrhage reported
in approximately 5%. Up to 3% of lung biopsies develop
pneumothorax requiring intercostal drainage.4e8 The
primary aim of this study was to evaluate the ability of
thoracic radiologists to accurately estimate the risk of
pneumothorax and pulmonary haemorrhage occurring
during individual co-axial cutting needle lung biopsies using
pre-biopsy staging CT images which had been marked with
the actual biopsy needle pathway. A secondary aim was to
evaluate which factors related to the patient, the lesion or
the techniques of biopsy were most strongly associated
with biopsy complications. Such findings may be relevant in
constructing a model aiding future risk assessment and in
terms of clinical governance.Materials and methods
Inclusion and exclusion criteria
All patients undergoing percutaneous CT-guided lung biopsy
at our institution between January 2000 and December
2004 were identified from the radiology database. Exclu-
sion criteria included patients with a pre-biopsy staging CT
scan performed >30 days prior to PCTTB, biopsies of
pleurally based mass lesions, biopsies performed under
fluoroscopic/ultrasound guidance and those patients with
uraemia. Platelet count, pro-thrombin (PT) and activated
partial thromboplastin time (APTT) were within normal
limits prior to all procedures. Furthermore, those CT-
guided lung biopsies performed without co-axial cutting
needles were also excluded. All remaining patients under-
going PCTTB during the 5-year period were included in the
study.
Biopsy protocol
All patients underwent a staging CT scan using either a GE
CT PACE Plusª single slice non-spiral scanner (between
January 2000 and January 2001) or a Toshiba Asteionª
multi-slice scanner using 8 mm cuts (after January 2001).
Systemic arterial blood pressure was checked before andafter the procedure. Biopsies were performed using a co-
axial cutting needle system (Cookª Co-axial Quick-Coreª
Biopsy Echotipª Needle Set; 19 gauge outer sheath; 20
gauge cutting needle) in the prone, supine or lateral
decubitus position depending on the location of the lesion.
Biopsies were performed under CT guidance by consultant
radiologists or by trainee radiologists under consultant
supervision. Following local anaesthesia the co-axial nee-
dle was inserted through a small skin incision, advanced to
the correct position and samples obtained. Immediately
post-biopsy, the presence of pneumothorax or haemor-
rhage was assessed by CT scanning. Patients were then
transferred to a medical ward and nursed in the supine
position for 2 h and fasted for 4 h. Pulse, blood pressure
and temperature were measured every 30 min for 2 h,
hourly for 4 h and then 4 hourly until discharge. A chest
radiograph was performed 3e4 h post-procedure or as
clinically indicated. All clinical findings, procedure notes,
nursing observations and complications are recorded on
a lung biopsy care pathway proforma according to local
protocol. On discharge patients were instructed to attend
a local Accident and Emergency Department if they
developed any symptoms of breathlessness, chest pain or
significant haemoptysis.
Study protocol
The clinical records of eachpatientwere reviewedbya single
investigator. The outcome and complications of each PCTTB
were recorded as well as the eventual diagnosis. Haemopt-
ysis as a presenting symptom, an established diagnosis of
systemic hypertension, details of smoking history, lung
function, seniority of the operator performing the PCTTB,
pre-biopsy and recovery blood pressure were recorded. A
radiologist not involved in the complication risk assessment
marked the path taken by the cutting needle using a wax
pencil on each patient’s pre-biopsy staging CT scan. Each
staging of CT scan was then reviewed independently by two
thoracic radiologists (radiologists 1 and 2) blinded to all the
clinical details andwhether procedure related complications
occurred. Each operator had a minimum of 15 years’ expe-
rience as a Consultant Radiologist in performing lung biopsies
and sub-specialised in this field.
Lesion characteristics including location, size (greatest
transverse diameter), depth from the pleura along the
biopsy track, whether the lesion abutted the pleural
surface and the presence of a lung fissure or blood vessel
intersecting the biopsy path were assessed and recorded by
each radiologist. The diameter of the main pulmonary
artery was recorded and dilatation was defined as a main
pulmonary artery diameter (MPAD) exceeding 29 mm and/
or exceeding the transverse diameter of the aorta in the
absence of structural aortic pathology.9 An emphysema
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moderate and severe) based on the CT appearances in the
lobe where the biopsy was performed.
Each radiologist used the CT data coupled with their own
knowledge and expertise to independently estimate the like-
lihood of pneumothorax and pulmonary haemorrhage occur-
ring during PCTTB by means of a percentage Visual Analogue
Scale (VAS). Prior to the study commencing, each radiologist
was trained in and gained familiarity with use of the VAS.
Pneumothorax was diagnosed either on the post-biopsy CT
screening or on subsequent chest radiography. Pulmonary
haemorrhage was defined as new airspace shadowing devel-
oping around the needle track or lesion post-biopsy with or
without any associated haemoptysis. Airflow obstruction on
spirometry was defined as an FEV1/FVC ratio< 70%. Formal
approval was granted for the study by our institution.
Statistical analysis
Statistical analysis was performed using the SPSSª software
package. Uni-variate analysis was performed using the Chi-
squared (c2) test in the case of categorical variables which
were not linked and with linear-by-linear analysis in the
case of linked categorical data. The two-tailed Manne
Whitney U test was used to analyse continuous data in the
absence of a normal distribution. Fisher’s Exact Test was
employed when dealing with groups containing compara-
tively fewer subjects. For factors associated with pneu-
mothorax or bleeding, following uni-variate analysis the 3
most statistically significant variables noted were subse-
quently entered into a backward stepwise multi-variate
logistic regression model. Statistical significance was
defined as a p value< 0.05.
Results
During the study period, 231 patients underwent image
guided lung biopsy at our institution of which 152Underwent cut
biopsy
n=134
Benign
diagnosis
n=3
Non-diag
n=48
Diagnosed malignancy
n=80
Radiological resolution
(Presumed inflammatory)
n=14
Subsequently diagnosed
malignancy
n=29
Figure 1 Outcome of percutaneopatients fulfilled study inclusion criteria. Of these,
complete imaging and medical records were available in
134 patients (mean age 68 (SD 10) years, 73 (54.5%)
male; outcome charted in Fig. 1). Twenty-one patients
underwent staging CT using a single slice scanner, the
remainder with a multi-slice scanner. In 2 patients who
underwent a repeat procedure, the outcome of the first
biopsy was used for the purpose of the study. Three
biopsies were abandoned prior to any tissue being
obtained; 2 due to pneumothorax and 1 due to patient
discomfort, these biopsies have been included in subse-
quent analysis. In the remaining 131 patients, 80 (61%)
were diagnosed with malignancy as a result of the lung
biopsy; 48 biopsies (37%) were non-diagnostic. Eighty-four
biopsies (63%) were performed by consultant radiologists
and 50 (37%) were undertaken by radiology trainees
under consultant supervision. Spirometry performed 4
weeks prior to PCTTB was available in 123 cases. Thirty-
four (25%) presented with haemoptysis and 40 (30%) had
an established diagnosis of systemic hypertension.
Radiologist estimation of the likelihood of
pneumothorax and pulmonary haemorrhage
complicating lung biopsy
Pneumothorax occurred in 32 of 134 cases (24%) of which 5
(4% of the total group or 16% of the pneumothorax group)
required intercostal drainage. The median risk of pneumo-
thorax was estimated at 0% (IQR 0e22.5%) by radiologist 1
and 15% (IQR 0e25%) by radiologist 2 for biopsies not
complicated by pneumothorax. However, in biopsies where
pneumothorax occurred, the risk was estimated as a median
of 22% (IQR 0e25%) and 25% (IQR 15e25%), respectively. Thus
the overall estimate of pneumothorax risk was significantly
higher for patients who developed a pneumothorax
compared with biopsies where this complication did not
occur (ManneWhitney U test; radiologist 1: zZ3.99,
p< 0.001; radiologist 2: zZ3.06, pZ 0.002).ting needle
nostic Abandoned
n=3
Specific benign diagnosis
n=4
DNA follow-up
n=1
us cutting needle lung biopsies.
Table 1 Accuracy of radiologists in estimating likelihood of pneumothorax complicating PCTTB.
Patients with estimated
pneumothorax risk< 20%
Patients with estimated
pneumothorax risk 20e49%
Patients with estimated
pneumothorax risk 50%
Significance
Actual pneumothorax
rate (radiologist 1)
15/96 (16%) 10/30 (33%) 7/8 (87%) p< 0.001
Actual pneumothorax
rate (radiologist 2)
9/65 (14%) 21/67 (31%) 2/2 (100%) p< 0.01
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estimated likelihood of pneumothorax as <20% in 96 (72%)
and 65 (48%) cases, respectively. In those cases where
estimated risk of pneumothorax was <20% by each radiol-
ogist, 16% and 14% of biopsies resulted in pneumothorax,
respectively. Radiologists 1 and 2 estimated likelihood of
pneumothorax as 20e49% in 30 (22%) and 67 (50%) cases
with the actual pneumothorax incidence observed at 33%
and 31%, respectively. Where the pneumothorax risk was
estimated at 50%, the incidence of pneumothorax rose to
87% and 100% (Table 1). The radiologists differed on the
classification of 31 cases in the <20% group, 37 cases in the
20e49% group and 6 cases in the 50% group; overall there
were 74 cases (55% of the cohort) where disagreement was
observed between the 2 radiologists in terms of risk clas-
sification of pneumothorax. The association between the
overall actual pneumothorax incidence and radiologist
estimation of likelihood was statistically significant (radi-
ologist 1: c2Z 22.89, p< 0.001; radiologist 2: c2Z 12.03,
p< 0.01; see Table 1). Biopsies complicated by pneumo-
thoraces requiring intercostal drainage had an estimated
median risk of 25% by both radiologists (IQR
0e62.5% and 12.5e37.5%).
There was no significant difference for either radiologist
in the assessment of risk of haemorrhage in those patientsTable 2 Demographics and variables associated with pneum
(medical variables).
Pneumothorax complicatin
PCTTB (n[ 32)
Age (years) 70 (64e77)a
Gender 11Z female (8%)
21Zmale (16%)
Operator seniority 14Z trainee (10%)
18Z consultant (13%)
FEV1 (percentage predicted) 77 (60e93)
a
(nZ 123) nZ 30
FVC (percentage predicted) 87 (75e96)a
(nZ 123) nZ 30
Smoking status NeverZ 1 (0.7%)
ExZ 17 (12.7%)
CurrentZ 14 (10.4%)
Total pack years smoked 40 (31e50)a
a Denotes median value (inter-quartile range).with and without this complication (median risk assessment
for biopsies not complicated by haemorrhage: radiologist
1 e 0% (IQR 0%), radiologist 2 e 10% (IQR 0e25%); median
risk for biopsies complicated by haemorrhage: radiologist
1 e 0% (IQR 0%), radiologist 2 e 0% (IQR 0e12.5%), Manne
Whitney U test; radiologist 1: zZ0.64; pZ 0.52; radiol-
ogist 2: zZ0.94; pZ 0.35).
Variables associated with pneumothorax
There was a highly significant statistical agreement between
the radiologists in assessing lesion size, lesion depth,
whether the lesion abutted the pleura, the biopsy path
crossing a fissure and the emphysema index (t-test;
p< 0.001). The statistically significant associations on uni-
variate analysis between the development of pneumothorax
and themedical and radiological variables are summarized in
Tables 2 and 3. On multi-variate analysis, the significant
associations with pneumothorax occurrence were the
absenceof the lesionabutting thepleura for both radiologists
(radiologist 1: 95% CIZ 0.07e0.46, p< 0.001; radiologist 2:
95% CIZ 0.14e0.90, pZ 0.03) with lesion size also being
significant for radiologist 2 (95% CIZ 0.57e0.94, pZ 0.02).
This variable did not quite reach statistical significance for
radiologist 1 (95% CIZ0.60 to 1.01, pZ 0.068).othorax complicating PCTTB following uni-variate analysis
g No pneumothorax complicating
PCTTB (nZ 102)
p value
71 (63e76)a pZ 0.76
50Z female (37%) pZ 0.15
52Zmale (39%)
36Z trainee (27%) pZ 0.39
66Z consultant (49%)
66 (50e87)a pZ 0.13
nZ 93
88 (76e98)a pZ 0.94
nZ 93
NeverZ 12 (9%) pZ 0.22
ExZ 49 (36.6%)
CurrentZ 41 (30.6%)
40 (25e54)a pZ 0.4
Table 3 Demographics and variables associated with pneumothorax complicating PCTTB following uni-variate analysis
(radiological variables).
Pneumothorax complicating
PCTTB (nZ 32)
No pneumothorax complicating
PCTTB (nZ 102)
p value
Location of lesion Upper lobeZ 19 Upper lobeZ 52 pZ 0.90
Lower lobeZ 12 Lower lobeZ 40
Hilar/mediastinalZ 1 Middle lobeZ 1
Hilar/mediastinalZ 6
OtherZ 3
Lesion size (cm) Rad 1: 3.00 (2.13e4)a Rad 1: 4.00 (3e6)a pZ 0.001
Rad 2: 3.00 (2.13e4)a Rad 2: 4.00 (3e6)a pZ 0.001
Lesion depth (cm) Rad 1: 1.5 (3e0.13)a Rad 1: 0 (0e1.5)a p< 0.001
Rad 2: 2.0 (3e0.13)a Rad 2: 0 (0e2)a pZ 0.001
Lesion abutting pleura Rad 1: nZ 24 (17.9%); yZ 8 (6%) Rad 1: nZ 29 (22%); yZ 73 (55%) p< 0.001
Rad 2: nZ 24 (17.9%); yZ 8 (6%) Rad 2: nZ 47 (35%); yZ 55 (41%) pZ 0.004
Presence of biopsy
path crossing lung fissure
Rad 1: nZ 29 (22%); yZ 3 (2%) Rad 1: nZ 92 (69%); yZ 10(8%) pZ 0.94
Rad 2: nZ 31 (23%); yZ 1 (0.7%) Rad 2: nZ 89 (66%); yZ 13 (10%) pZ 0.12
Emphysema index
(no of cases)
Rad 1 Nil/mildZ 16; mod/severeZ 16 Nil/mildZ 60; mod/severeZ 42 pZ 0.20
Rad 2 Nil/mildZ 21; mod/severeZ 11 Nil/mildZ 76; mod/severeZ 26 pZ 0.46
a Denotes median value (inter-quartile range).
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episodes) of which 11% (3/27) were complicated by pneu-
mothorax compared with 28% (27/96) of patients without
obstructive spirometry (c2Z 13.67, pZ 0.08, non-signifi-
cant). FEV1 was <1 l in 8 patients in whom 2 biopsies were
complicated by pneumothorax, with 1 requiring interven-
tion.Of these8biopsies, radiologists 1 and2 judged the lesion
tobeadherent to thepleura in7 and6cases, respectively. For
both radiologists, lesions that were found to be greater than
3 cm in size and simultaneously abutting the pleura were
much less likely to be associated with pneumothorax than
lesions 3 cm in size and 2 cm in depth (radiologist 1:
c2Z 20.83, p< 0.001; radiologist 2: c2Z 15.53, p< 0.001).
Variables associated with pulmonary haemorrhage
Pulmonary haemorrhage occurred in only 5 biopsies (3.7%)
in total. All were self-limiting with one case resulting in
haemoptysis. None required blood transfusion and the yield
of malignancy was not significantly different from those
biopsies not associated with pulmonary haemorrhage. The
only statistically significant association between the
medical and radiological variables and pulmonary haemor-
rhage was a higher cumulative pack year smoking history
(ManneWhitney U test; zZ2.34, pZ 0.018). A non-
significant trend was noted towards increasing age and
increased rate of pulmonary haemorrhage (ManneWhitney
U test; zZ1.76, pZ 0.08). Of the biopsies performed in
the 34 patients presenting with haemoptysis prior to
PCTTB, none were complicated by haemorrhage. In the 40
patients with an established diagnosis of systemichypertension pre-biopsy, only 1 biopsy resulted in pulmo-
nary haemorrhage. The presence or absence of pulmonary
artery dilatation could be assessed in all but 10 cases for
each radiologist. Radiologists 1 and 2 noted the presence of
pulmonary artery dilatation in 6 and 7 cases, respectively,
and none of these were complicated by pulmonary hae-
morrhage. It was noted that the biopsy needle path crossed
a pulmonary blood vessel in 8 and 15 cases by radiologists 1
and 2, respectively, yet pulmonary haemorrhage occurred
in 0/8 biopsies (radiologist 1) and 1/15 biopsies (radiologist
2). Operator seniority, size and location of the lesion
and the histology of the biopsied lesion had no significant
effect upon the incidence of pulmonary haemorrhage.Discussion
The decision to undertake percutaneous lung biopsy depends
on the site of the abnormality, the performance status and
co-morbidities as well as the influence lung biopsy is likely to
have on patient management. In the literature there is
paucity of data on ability of radiologists and other clinicians
to estimate the occurrence of lung biopsy complications. We
can find only one previous study which addresses this issue.10
In a study of 160 patients undergoing percutaneous lung
biopsy, 3 radiologists and 1 pulmonologist, all blinded to the
outcome of needle biopsy, reviewed pre-biopsy chest
radiographs and pulmonary function tests. They concluded
that obstructive lung function diagnosed by spirometry was
a useful parameter in predicting the occurrence of pneu-
mothorax but evaluation of the chest radiograph was less
454 B. Chakrabarti et al.useful. In our cohort, there was significant disagreement
between radiologists in estimation of pneumothorax occur-
rence in individual patients. For example, radiologist 1
estimated pneumothorax risk between 20% and 49% in 22% of
cases. This differed markedly with radiologist 2 who esti-
mated that 50% of cases carried a pneumothorax risk of
between 20% and 49%. Overall, disagreement in pneumo-
thorax estimationwas noted in just over half the cases. The 5
pneumothoraces requiring intercostal drainage were not
associated with any particular risk stratification and thus the
ability to predict this complication also seems poor i.e. the
median estimated risk of pneumothorax in this group was
only 25%. The actual pneumothorax incidence was found to
be 16% and 14% in the<20% group, 33% and 31% in the 20e49%
group and 87% and 100% in the50% groupwith radiologists 1
and 2, respectively. Our findings suggest that although radi-
ologists are able to predict the proportion of pneumo-
thoraces occurring in a cohort of patients, they were unable
to do this on an individual case by case basis even with
appropriate radiological information.
The correlation between lesion size and location
measured by the radiologists and the development of
pneumothorax were generally in keeping with the reported
studies.4,5,11e15,20 Previous literature suggests that the
passage of the biopsy needle through aerated lung
increases the risk of pneumothorax.4,11,12 In keeping with
the literature our study has shown a 6-fold increased inci-
dence of pneumothorax in biopsies performed on smaller
and deeper lesions and those which do not abut the pleura.
Consistent with the findings of one previous study pneu-
mothorax was not associated with lobar anatomical loca-
tion of the lesion.15 In addition, there was no association
with pneumothorax and the biopsy needle crossing a major
lung fissure and to our knowledge this possible association
has not been previously examined. There is conflicting
evidence regarding airflow obstruction and radiological
evidence of emphysema in the development of pneumo-
thorax.4,5,14e19 In keeping with Yeow et al.,4 in our study
the emphysema index of the lobe containing the lesion did
not significantly affect incidence of pneumothorax.
However, in one previous study, pneumothorax occurred in
14% of biopsies and was associated with radiological
evidence of emphysema and/or pulmonary fibrosis, in
lesions located anteriorly and not involving the pleural
surface.17 Our data demonstrated that in our patient group
neither obstructive spirometry nor lung function level was
associated with a significantly increased risk of pneumo-
thorax. One of the biopsies in the 8 patients with an FEV1
less than 1 l required intervention for pneumothorax. The
majority of these lesions were adherent to the pleura and
we must assume that they were selected for lung biopsy as
they were deemed to have a lower pneumothorax risk. This
does, however, reinforce the national guidelines recom-
mendation that impaired lung function alone should not be
an absolute contraindication to lung biopsy.7 In all studies
in this area, however, including our own, there is likely to
be an element of selection bias in that clinicians may have
been more reluctant to refer patients with very abnormal
spirometry or obvious emphysema for lung biopsy.
Pulmonary haemorrhage remains a rare complication of
co-axial lung biopsy. The ability to estimate this compli-
cation was no better than chance. Pulmonary haemorrhagewas not associated with a pre-biopsy haemoptysis, an
established diagnosis of systemic hypertension, a signifi-
cantly elevated systemic blood pressure or the biopsy path
traversing a pulmonary blood vessel. Previous studies have
found a higher rate of pulmonary haemorrhage than seen in
our study.4,20 Although the presence of pulmonary hyper-
tension has been described as a risk factor for pulmonary
haemorrhage, none of the cases in our study with radio-
logical evidence of pulmonary artery dilatation were asso-
ciated with bleeding.7 Moreover, contrary to other studies,
lesion size, depth and histological diagnosis did not affect
the risk of pulmonary haemorrhage although sample size
and the low incidence of this complication may account for
these differences.4,5 In our study there is a previously
unreported association between the number of pack years
and pulmonary haemorrhage. The reasons for this are
unclear but may be due to lung parenchymal damage pre-
disposing to haemorrhage.
There are several limitations to our study. The diagnosis of
pneumothorax was by means of CT screening immediately
after thebiopsyor a chest radiographperformedafter several
hours1,3,4,18 It is therefore possible that clinically silent
delayed onset pneumothoraces may have been missed prior
to or after hospital discharge. The process of risk assessment
by radiologists in terms of a given complication during PCTTB
may be subject to bias and hence differ between radiologists
based on level of expertise and previous clinical experience.
The radiologists were also blinded to the clinical details such
as results of pulmonary function tests which if known may
have altered the risk estimation. The emphysema score used
by the radiologists in our study was a non-standardized index
based on the individual judgement of the radiologist
regarding extent of emphysema in the lobe containing the
lesion. Further studies are needed to determine whether the
presence of emphysema measured by standardized criteria
either globally or in the lobe containing the lesion represents
a factor for the development of pneumothorax.21 The angle
of needle trajectory was not measured in this study; this has
been shown in one previous study to be an important factor in
the development of pneumothorax.15 The duration of the
cutting needle remaining in the chest during each biopsy was
not measured and this may have been a factor related to the
development of pneumothorax. In addition, biopsies per-
formedunder ultrasound guidancewerenot included and this
may have affected the incidence of pneumothorax as ultra-
sonography is more likely to be employed with peripheral
lesions. Although consistent with guidelines and previous
studies, the small numberof patientswithcomplications such
as pulmonary haemorrhage raises the possibility of a b error.7
Nevertheless, themain conclusions of the study in relation to
pulmonary haemorrhage did not seem to be affected (i.e.
a lack of association of haemorrhage with systemic hyper-
tension, elevated peri-biopsy blood pressure and pre-biopsy
haemoptysis). Thecriteria for pulmonaryarteryhypertension
used in our study do not represent a diagnostic gold standard
but a radiological surrogate. Finally, in our study, the two
radiologists were specialised in thoracic radiology and this
may not reflect the situation in other hospitals in the UK.
In conclusions, our data show that thoracic radiologists
differ in the risk estimation of pneumothorax occurring in
individual patients undergoing co-axial cutting needle lung
biopsy. Furthermore, they were unable to predict
Risk assessment for percutaneous lung biopsy 455pneumothorax occurrence on an individual case by case
basis unless it was deemed that there was a high risk of
pneumothorax i.e. 1 in 2 or higher. Moreover, this study
reaffirms the advice that poor pulmonary function alone
need not necessarily exclude co-axial cutting needle lung
biopsy. Pulmonary haemorrhage is a rare complication and
this study demonstrates that it is difficult to predict accu-
rately even when measuring systemic hypertension and
surrogates for pulmonary hypertension. Finally our study
reinforces the fact that pneumothorax and/or pulmonary
haemorrhage may occur even if the estimation of these
complications occurring is very low. Thus it is always
important to estimate each patient’s ability to withstand
a significant pneumothorax/and or significant pulmonary
haemorrhage should they occur. This remains a clinical
judgement that should preferably be made at a multidisci-
plinary meeting.
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